Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- EU parliament adopts law to enable longer cross border freight trains
- New EU regulation on human tissue and blood safety passed by European Parliament
- Generational renewal, the EU’s unfinished business
- The case for a European Green Industrial Deal
- Germany, France table reform of European defence cooperation scheme
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
Subscribe to our jobletter!